Serving 500+ biopharmaceutical companies globally:

Deloitte
Moodys
Cipla
Mallinckrodt
Colorcon
Federal Trade Commission
Argus Health
Medtronic
Harvard Business School
Teva

Get Deeper Knowledge, Faster

Core Data

$ 1000/3 months
Best for short-term projects
$ 2995/year
25% savings
Inquire about site licenses or API access
Email Alerts and Data Export
Detailed Regulatory Status
US & International Patent Data
-
-
-
-
-
-
Biologic Drug Patents
(optional add-on) inquire
Patents on Drugs in Development
(optional add-on) inquire
Multiple Users
inquire
 Most Popular

Patents Plus

$ 1350/3 months
Best for short-term projects
$ 3995/year
25% savings
Inquire about site licenses or API access
Email Alerts and Data Export
Detailed Regulatory Status
US & International Patent Data
Finished Product Suppliers
Non-Orange Book Patents
Expired Patents
-
-
-
Biologic Drug Patents
(optional add-on) inquire
Patents on Drugs in Development
(optional add-on) inquire
Multiple Users
inquire
 Most Comprehensive

Forecasting

$ 2700/3 months
Best for short-term projects
$ 7995/year
25% savings
Inquire about site licenses or API access
Email Alerts and Data Export
Detailed Regulatory Status
US & International Patent Data
Finished Product Suppliers
Non-Orange Book Patents
Expired Patents
Patent Applications
Bulk API Vendors
Clinical Trials
Biologic Drug Patents
(optional add-on) inquire
Patents on Drugs in Development
(optional add-on) inquire
Multiple Users
inquire

Request a Callback or Demo

Name: *
Email: *
Company: *
Telephone: *
Message:

Pick Your Plan

 Most Popular  Most Comprehensive
Feature Core Data Patents Plus Forecasting Plan
Patents
Detailed Patent Information
International Patent Data
Supplementary Protection Certificates (SPCs)
Non-Orange Book Patents -
Expired Patents (1986 - Present) -
Patent Applications
Abandoned Patents - -
Pending Patent Applications - -
Granted Patent Applications - -
Patent Maintenance - -
Clinical Trials
Condition MeSH Terms - -
Trial Locations - -
Trial Progress - -
Trial Sponsors - -
Regulatory
Detailed Regulatory Status
Paragraph IV Challenges
Tentative Approvals (indicates impending generic entry)
Drug Master File Listings
Authorized Generics -
Drug Information
Comprehensive Drug Information
Drug Class
Suppliers -
Bulk API Vendors - -
Manufacturing - -
Additional Features
Email Alerts
Data Export
Dynamic Trend Graphs
Price / Year $2995 $3995 $7995
► INSTANT ACCESS
Inquire about site licenses
► INSTANT ACCESS
Inquire about site licenses
► INSTANT ACCESS
Inquire about site licenses

Frequently Asked Questions

DrugPatentWatch has patent coverage for the following countries and regional organizations:

African Intellectual Property Organization (OAPI) African Regional IP Organization (ARIPO) Algeria Argentina Australia Austria Bahrain (GCC) Belgium Benin (OAPI) Bosnia and Herzegovina Botswana (ARIPO) Brazil Bulgaria Burkina Faso (OAPI) Cameroon (OAPI) Canada Central African Republic (OAPI) Chad (OAPI) Chile China Colombia Comoros (OAPI) Congo-Brazzaville (OAPI) Costa Rica Croatia Cuba Cyprus Czech Republic Czechoslovakia Côte d'Ivoire (OAPI) Denmark Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea (OAPI) Estonia Eurasian Patent Organization European Patent Office Finland France Gabon (OAPI) Georgia, Republic of German Democratic Republic Germany Ghana (ARIPO) Greece Guatemala Guinea (OAPI) Guinea-Bissau (OAPI) Gulf Cooperation Council Honduras Hong Kong Hungary Iceland India Indonesia Ireland Israel Italy Japan Jordan Kenya (ARIPO) Kuwait (GCC) Latvia Lesotho (ARIPO) Liberia (ARIPO) Lithuania Luxembourg Malawi (ARIPO) Malaysia Mali (OAPI) Mauritania (OAPI) Mexico Moldova, Republic of Monaco Montenegro Morocco Mozambique (ARIPO) Namibia (ARIPO) Netherlands New Zealand Nicaragua Niger (OAPI) Norway Oman (GCC) Panama Peru Philippines Poland Portugal Qatar (GCC) Romania Russian Federation Rwanda (ARIPO) San Marino Saudi Arabia Saudi Arabia (GCC) Senegal (OAPI) Serbia Sierra Leone (ARIPO) Singapore Slovakia Slovenia Somalia (ARIPO) South Africa South Korea Spain Sudan (ARIPO) Swaziland (ARIPO) Sweden Switzerland São Tomé and Príncipe (ARIPO) Taiwan Tajikistan Tanzania (ARIPO) The Gambia (ARIPO) Togo (OAPI) Tunisia Turkey Uganda (ARIPO) Ukraine United Arab Emirates (GCC) United Kingdom United States of America Uruguay Viet Nam Yugoslavia Zambia (ARIPO) Zimbabwe (ARIPO)

Adding an alert is as easy as clicking the 'Add Alert' button on a page of interest.

    Available alerts include:

  • Paragraph IV challenges
  • New drugs and added or expired patents per company
  • Added or expired patents per drug
  • Tentative approvals

Enterprise Plans are available for unlimited users within your organization. The other plans cannot be shared, but multiple accounts can be purchased for a substantial discount. For more information on enterprise plans, please contact us

Please use the contact form and tell us which subscription plan you would like an invoice for.

No problem. Please use the contact form and let us know how we can be of assistance.

Clients in 53 Countries

DrugPatentWatch cited by CNN, NEJM, Nature Journals, and more …

Fortune- Generics' new legal attack: Big Pharma's aging patents CNN Money - Generics' new legal attack: Big Pharma's aging patents New England Journal of Medicine Barrons

Globalization of Pharmaceutical Drug Innovation The structure and business of biopharmaceutical companies including the management of risks and resources Drug Topics Nature Biotechnology Cardinal Health Business Insider National Bureau of Economic Research

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot